Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Budczies J"'
Autor:
Barupal DK; West Coast Metabolomics Center, University of California, Davis, CA, USA.; Co-first authors and contributed equally to this work., Gao B; West Coast Metabolomics Center, University of California, Davis, CA, USA.; Co-first authors and contributed equally to this work., Budczies J; Institute of Pathology, Charité University Hospital, Berlin, Germany., Phinney BS; UC Davis Genome Center, University of California, Davis, CA, USA., Perroud B; UC Davis Genome Center, University of California, Davis, CA, USA., Denkert C; Institute of Pathology, Charité University Hospital, Berlin, Germany.; German Institute of Pathology, Philipps-University Marburg, Marburg, Germany., Fiehn O; West Coast Metabolomics Center, University of California, Davis, CA, USA.
Publikováno v:
Oncotarget [Oncotarget] 2019 Jun 11; Vol. 10 (39), pp. 3894-3909. Date of Electronic Publication: 2019 Jun 11 (Print Publication: 2019).
Autor:
Christopoulos P; Department of Thoracic Oncology, Thoraxklinik and National Center for Tumor Diseases at Heidelberg University Hospital, Baden Württemberg, Heidelberg, Germany.; Translational Lung Research Center Heidelberg, Member of the German Center for Lung Research, Baden Württemberg, Heidelberg, Germany., Budczies J; Institute of Pathology, Heidelberg University Hospital, Baden Württemberg, Heidelberg, Germany., Kirchner M; Institute of Pathology, Heidelberg University Hospital, Baden Württemberg, Heidelberg, Germany., Dietz S; Division of Cancer Genome Research, German Cancer Research Center and National Center for Tumor Diseases, Baden Württemberg, Heidelberg, Germany., Sültmann H; Division of Cancer Genome Research, German Cancer Research Center and National Center for Tumor Diseases, Baden Württemberg, Heidelberg, Germany., Thomas M; Department of Thoracic Oncology, Thoraxklinik and National Center for Tumor Diseases at Heidelberg University Hospital, Baden Württemberg, Heidelberg, Germany.; Translational Lung Research Center Heidelberg, Member of the German Center for Lung Research, Baden Württemberg, Heidelberg, Germany., Stenzinger A; Institute of Pathology, Heidelberg University Hospital, Baden Württemberg, Heidelberg, Germany.
Publikováno v:
Oncotarget [Oncotarget] 2019 May 03; Vol. 10 (33), pp. 3093-3103. Date of Electronic Publication: 2019 May 03 (Print Publication: 2019).
Autor:
Helbig D; Department of Dermatology, University Hospital Cologne, Cologne, Germany., Quaas A; Institute of Pathology, University Hospital Cologne, Cologne, Germany., Mauch C; Department of Dermatology, University Hospital Cologne, Cologne, Germany., Merkelbach-Bruse S; Institute of Pathology, University Hospital Cologne, Cologne, Germany., Büttner R; Institute of Pathology, University Hospital Cologne, Cologne, Germany., Emberger M; Institute of Pathology, Salzburg, Austria., Wobser M; Department of Dermatology, University Hospital Würzburg, Würzburg, Germany., Rüsseler V; Institute of Pathology, University Hospital Cologne, Cologne, Germany., Pütz K; Institute of Pathology, University Hospital Cologne, Cologne, Germany., Binot E; Institute of Pathology, University Hospital Cologne, Cologne, Germany., Rehker J; Institute of Pathology, University Hospital Cologne, Cologne, Germany., Budczies J; Institute of Pathology, Charité University Hospital, Berlin, Germany., Ihle MA; Institute of Pathology, University Hospital Cologne, Cologne, Germany.
Publikováno v:
Oncotarget [Oncotarget] 2017 Nov 25; Vol. 8 (65), pp. 109457-109467. Date of Electronic Publication: 2017 Nov 25 (Print Publication: 2017).
Autor:
Braicu EI; Department of Gynecology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.; On Behalf of the Tumor Bank Ovarian Cancer Network, Berlin, Germany., Darb-Esfahani S; Institute of Pathology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Tumor bank Ovarian Cancer Network, Berlin, Germany.; On Behalf of the Tumor Bank Ovarian Cancer Network, Berlin, Germany., Schmitt WD; Institute of Pathology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Tumor bank Ovarian Cancer Network, Berlin, Germany., Koistinen KM; Zora Biosciences Oy, Espoo, Finland., Heiskanen L; Zora Biosciences Oy, Espoo, Finland., Pöhö P; VTT Technical Research Centre of Finland, Espoo, Finland.; Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland., Budczies J; Institute of Pathology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Tumor bank Ovarian Cancer Network, Berlin, Germany., Kuhberg M; Department of Gynecology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany., Dietel M; Institute of Pathology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Tumor bank Ovarian Cancer Network, Berlin, Germany., Frezza C; MRC Cancer Unit, Hutchison/MRC Research Centre, University of Cambridge, Cambridge, UK., Denkert C; Institute of Pathology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Tumor bank Ovarian Cancer Network, Berlin, Germany., Sehouli J; Department of Gynecology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.; On Behalf of the Tumor Bank Ovarian Cancer Network, Berlin, Germany., Hilvo M; Zora Biosciences Oy, Espoo, Finland.; VTT Technical Research Centre of Finland, Espoo, Finland.
Publikováno v:
Oncotarget [Oncotarget] 2017 Oct 26; Vol. 8 (61), pp. 102912-102922. Date of Electronic Publication: 2017 Oct 26 (Print Publication: 2017).
Autor:
Menyhart O; Semmelweis University 2nd Department of Pediatrics, Budapest, Hungary., Budczies J; Institute of Pathology, Charité University Hospital, Berlin, Germany., Munkácsy G; Semmelweis University 2nd Department of Pediatrics, Budapest, Hungary., Esteva FJ; Clinical Cancer Center, NYU Langone Medical Center, New York, NY, USA., Szabó A; Semmelweis University 2nd Department of Pediatrics, Budapest, Hungary., Miquel TP; New Terapeutics Targets Laboratory (TargetsLab), Department of Medical Sciences, University of Girona, Girona, Spain., Győrffy B; Semmelweis University 2nd Department of Pediatrics, Budapest, Hungary.; MTA TTK Lendület Cancer Biomarker Research Group, Institute of Enzymology, Budapest, Hungary.
Publikováno v:
Oncotarget [Oncotarget] 2017 Aug 24; Vol. 8 (44), pp. 77207-77218. Date of Electronic Publication: 2017 Aug 24 (Print Publication: 2017).
Autor:
Budczies J; Institute of Pathology, Charité University Hospital, Berlin, Germany.; German Cancer Consortium (DKTK), partner sites Berlin, Heidelberg and Munich, Germany., Pfarr N; German Cancer Consortium (DKTK), partner sites Berlin, Heidelberg and Munich, Germany.; Institute of Pathology, University Hospital, Heidelberg, Germany.; Institute of Pathology, Technical University Munich (TUM), Munich, Germany., Stenzinger A; German Cancer Consortium (DKTK), partner sites Berlin, Heidelberg and Munich, Germany.; Institute of Pathology, University Hospital, Heidelberg, Germany.; National Center for Tumor Diseases (NCT), Heidelberg, Germany.; Department of Pathology, Center for Integrated Diagnostics (CID), Massachusetts General Hospital/Harvard Medical School, Boston, USA., Treue D; Institute of Pathology, Charité University Hospital, Berlin, Germany., Endris V; German Cancer Consortium (DKTK), partner sites Berlin, Heidelberg and Munich, Germany.; Institute of Pathology, University Hospital, Heidelberg, Germany., Ismaeel F; Department of Gynecology, Charité University Hospital, Berlin, Germany., Bangemann N; Interdisciplinary Breast Center, Charité University Hospital, Berlin, Germany., Blohmer JU; Interdisciplinary Breast Center, Charité University Hospital, Berlin, Germany., Dietel M; Institute of Pathology, Charité University Hospital, Berlin, Germany.; German Cancer Consortium (DKTK), partner sites Berlin, Heidelberg and Munich, Germany., Loibl S; German Breast Group (GBG), Neu-Isenburg, Germany., Klauschen F; Institute of Pathology, Charité University Hospital, Berlin, Germany., Weichert W; German Cancer Consortium (DKTK), partner sites Berlin, Heidelberg and Munich, Germany.; Institute of Pathology, University Hospital, Heidelberg, Germany.; Institute of Pathology, Technical University Munich (TUM), Munich, Germany.; National Center for Tumor Diseases (NCT), Heidelberg, Germany., Denkert C; Institute of Pathology, Charité University Hospital, Berlin, Germany.; German Cancer Consortium (DKTK), partner sites Berlin, Heidelberg and Munich, Germany.
Publikováno v:
Oncotarget [Oncotarget] 2016 Mar 15; Vol. 7 (11), pp. 13236-47.
Autor:
Darb-Esfahani S; Institute of Pathology, Charité Universitätsmedizin Berlin, Berlin, Germany.; Tumorbank Ovarian Cancer Network, Department of Gynecology, Charité Universitätsmedizin Berlin, Berlin, Germany., Kunze CA; Institute of Pathology, Charité Universitätsmedizin Berlin, Berlin, Germany., Kulbe H; Tumorbank Ovarian Cancer Network, Department of Gynecology, Charité Universitätsmedizin Berlin, Berlin, Germany.; Department of Gynecology, Charité Universitätsmedizin Berlin, Berlin, Germany., Sehouli J; Tumorbank Ovarian Cancer Network, Department of Gynecology, Charité Universitätsmedizin Berlin, Berlin, Germany.; Department of Gynecology, Charité Universitätsmedizin Berlin, Berlin, Germany., Wienert S; Institute of Pathology, Charité Universitätsmedizin Berlin, Berlin, Germany.; VM Scope GmbH, Berlin, Germany., Lindner J; Institute of Pathology, Charité Universitätsmedizin Berlin, Berlin, Germany., Budczies J; Institute of Pathology, Charité Universitätsmedizin Berlin, Berlin, Germany., Bockmayr M; Institute of Pathology, Charité Universitätsmedizin Berlin, Berlin, Germany., Dietel M; Institute of Pathology, Charité Universitätsmedizin Berlin, Berlin, Germany., Denkert C; Institute of Pathology, Charité Universitätsmedizin Berlin, Berlin, Germany.; Tumorbank Ovarian Cancer Network, Department of Gynecology, Charité Universitätsmedizin Berlin, Berlin, Germany., Braicu I; Tumorbank Ovarian Cancer Network, Department of Gynecology, Charité Universitätsmedizin Berlin, Berlin, Germany.; Department of Gynecology, Charité Universitätsmedizin Berlin, Berlin, Germany., Jöhrens K; Institute of Pathology, Charité Universitätsmedizin Berlin, Berlin, Germany.
Publikováno v:
Oncotarget [Oncotarget] 2016 Jan 12; Vol. 7 (2), pp. 1486-99.
Autor:
Budczies J; Institute of Pathology, Charité University Hospital, Berlin, Germany. German Cancer Research Center (DKFZ), Heidelberg, Germany. German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany., von Winterfeld M; Institute of Pathology, Charité University Hospital, Berlin, Germany., Klauschen F; Institute of Pathology, Charité University Hospital, Berlin, Germany., Bockmayr M; Institute of Pathology, Charité University Hospital, Berlin, Germany., Lennerz JK; Massachusetts General Hospital/Harvard Medical School, Department of Pathology, Boston, MA, USA., Denkert C; Institute of Pathology, Charité University Hospital, Berlin, Germany. German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany., Wolf T; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany. German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany., Warth A; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany., Dietel M; Institute of Pathology, Charité University Hospital, Berlin, Germany., Anagnostopoulos I; Institute of Pathology, Charité University Hospital, Berlin, Germany., Weichert W; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany. German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany. National Center for Tumor Diseases (NCT),Heidelberg, Germany., Wittschieber D; Institute of Legal Medicine, University Hospital Münster, Münster, Germany., Stenzinger A; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.
Publikováno v:
Oncotarget [Oncotarget] 2015 Jan 01; Vol. 6 (1), pp. 570-83.
Autor:
Kriegsmann M; Institute of Pathology, University of Heidelberg, Germany., Endris V; Institute of Pathology, University of Heidelberg, Germany. German Cancer Research Center, Heidelberg, Germany., Wolf T; Institute of Pathology, University of Heidelberg, Germany., Pfarr N; Institute of Pathology, University of Heidelberg, Germany., Stenzinger A; Institute of Pathology, University of Heidelberg, Germany., Loibl S; German Breast Group, Neu-Isenburg, Germany., Denkert C; Institute of Pathology, University Hospital Charité Berlin, Germany. German Cancer Consortium (DKTK), Germany., Schneeweiss A; National Center for Tumor Diseases, Heidelberg, Germany. German Cancer Consortium (DKTK), Germany., Budczies J; Institute of Pathology, University Hospital Charité Berlin, Germany. German Cancer Consortium (DKTK), Germany., Sinn P; Institute of Pathology, University of Heidelberg, Germany., Weichert W; Institute of Pathology, University of Heidelberg, Germany. National Center for Tumor Diseases, Heidelberg, Germany. German Cancer Consortium (DKTK), Germany.
Publikováno v:
Oncotarget [Oncotarget] 2014 Oct 30; Vol. 5 (20), pp. 9952-65.